(Q38575410)

English

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.

scientific article published on September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

atherosclerosis

1 reference

based on heuristic

inferred from title

Alberico L. Catapano

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Francesco Cosentino

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Riccardo C Bonadonna

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jean Ferrières

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Michal Vrablík

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Meral Kayikcioglu

11

object named as

Meral Kayikcioglu

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

14

object named as

Željko Reiner

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Carlos Aguiar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Eduardo Alegria

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Michel Farnier

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Pasquale Perrone Filardi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alberto Mello E Silva

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jesus Millan

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lale Tokgozoglu

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Paul Valensi

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Margus Viigimaa

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alberto Zambon

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

José Luis Zamorano

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Roberto Ferrari

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

1 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Atherosclerosis. Supplements

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1-12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherogenic dyslipidemia: prevalence and management in lipid clinics

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-density lipoproteins: a consensus statement from the National Lipid Association

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HDL-mediated mechanisms of protection in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of risk factors in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglycerides and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonfasting triglycerides and risk of ischemic stroke in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Major lipids, apolipoproteins, and risk of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Remnant cholesterol as a causal risk factor for ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: a flag for non-HDL-C.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs of Diabetes Mellitus (CoDiM) in Germany, direct per-capita costs of managing hyperglycaemia and diabetes complications in 2010 compared to 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The health care costs of diabetic peripheral neuropathy in the US.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Residual microvascular risk in diabetes: unmet needs and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipids, lipid-lowering therapy and diabetes complications

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated triglycerides correlate with progression of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-density lipoproteins and risk for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy in dyslipidemia: where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Residual macrovascular risk in 2013: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined therapy in the treatment of dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of medical therapies on retinopathy progression in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination lipid therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of fibrates on metabolism of statins in human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid-modifying therapies and risk of pancreatitis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

How do we improve patient compliance and adherence to long-term statin therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co‐administered with metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2815%2930001-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1567-5688(15)30001-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315511%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38575410&oldid=2153461364"